ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
Keilholz, U., Ascierto, P.A., Dummer, R., Robert, C., Lorigan, P., van Akkooi, A., Arance, A., Blank, C.U., Chiarion Sileni, V., Donia, M., Faries, M.B., Gaudy-Marqueste, C., Gogas, H., Grob, J.J., Guckenberger, M., Haanen, J., Hayes, A.J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V.K., Tawbi, H., Testori, A., Michielin, O.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
“Symptomatic” melanoma brain metastases: A call for clear definitions and adoption of standardized tools
Le Rhun, E., Weller, M., Anders, C., Larkin, J., Li, J., Moss, N.S., Tawbi, H., Dummer, R.
Published in European journal of cancer (1990) (01.09.2024)
Published in European journal of cancer (1990) (01.09.2024)
Get full text
Journal Article
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
Michielin, O., van Akkooi, A., Lorigan, P., Ascierto, P.A., Dummer, R., Robert, C., Arance, A., Blank, C.U., Chiarion Sileni, V., Donia, M., Faries, M.B., Gaudy-Marqueste, C., Gogas, H., Grob, J.J., Guckenberger, M., Haanen, J., Hayes, A.J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V.K., Tawbi, H., Testori, A., Keilholz, U.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
Tawbi, H.A., Beumer, J.H., Tarhini, A.A., Moschos, S., Buch, S.C., Egorin, M.J., Lin, Y., Christner, S., Kirkwood, J.M.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma
Tetzlaff, M.T., Adhikari, C., Lo, S., Rawson, R.V., Amaria, R.N., Menzies, A.M., Wilmott, J.S., Ferguson, P.M., Ross, M.I., Spillane, A.J., Vu, K.A., Ma, J., Ning, J., Haydu, L.E., Saw, R.P.M., Wargo, J.A., Tawbi, H.A., Gershenwald, J.E., Long, G.V., Davies, M.A., Scolyer, R.A.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
Eroglu, Z, Tawbi, H A, Hu, J, Guan, M, Frankel, P H, Ruel, N H, Wilczynski, S, Christensen, S, Gandara, D R, Chow, W A
Published in British journal of cancer (12.05.2015)
Published in British journal of cancer (12.05.2015)
Get full text
Journal Article
Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours
TAWBI, H. A, VILLARUZ, L, TARHINI, A, MOSCHOS, S, SULECKI, M, VIVERETTE, F, SHIPE-SPOTLOE, J, RADKOWSKI, R, KIRKWOOD, J. M
Published in British journal of cancer (06.09.2011)
Published in British journal of cancer (06.09.2011)
Get full text
Journal Article
CA224-047: A randomized, double-blind, phase II/III study of relatlimab (anti–LAG-3) in combination with nivolumab (anti–PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
Lipson, E.J., Long, G.V., Tawbi, H., Schadendorf, D., Atkinson, V.G., Maurer, M., Simonsen, K.L., Harbison, C., Hodi, F.S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)
Glitza, I.C., Rohlfs, M.L., Iqbal, M., Richard, J., Burton, E., Duncan, S., Brown, C., Anderson, J., Hwu, P., Hwu, W.-J., Wong, M., Yee, C., Patel, S., Woodman, S., Amaria, R., Diab, A., Tawbi, H., Davies, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
MC13-0078 PARP1 variants associated with response to Temozolomide in metastatic melanoma patients
Sedgewick, A, Romkes, M, Buch, S, Villaruz, L, Abecassis, I, Saul, M, Kirkwood, J.M, Benos, P.V, Tawbi, H
Published in European journal of cancer (1990) (01.11.2013)
Published in European journal of cancer (1990) (01.11.2013)
Get full text
Journal Article
Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma
Eriksson, Hanna, Hansson, Johan, Krynitz, Britta, Masucci, Giuseppe, Girnita, Ada, Lapins, Jan, Huen, Auris O, Tawbi, Hussein A, Davies, Michael A, Tetzlaff, Michael T, Curry, Jonathan L
Published in Acta dermato-venereologica (26.11.2020)
Published in Acta dermato-venereologica (26.11.2020)
Get full text
Journal Article
AB1441 LEARNING NEEDS ASSESSMENT FOR PATIENTS WITH CANCER AND A PRE-EXISTING AUTOIMMUNE DISEASE WHO ARE CANDIDATES TO RECEIVE IMMUNE CHECKPOINT INHIBITORS
Lopez-Olivo, M. A., Ruiz, J. I., Duhon, G. F., Altan, M., Tawbi, H., Diab, A., Bingham, C., Calabrese, C., Volk, R., Suarez-Almazor, M.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
1337PAnalysis of pyrexia in patients (pts) treated with dabrafenib (D) and/or trametinib (T) across clinical trials
Robert, C, Schadendorf, D, Dummer, R, Flaherty, K T, Tawbi, H A, Menzies, A M, D’Amelio, A, de Jong, E, Gasal, E, Long, G V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1360PIntracranial anti-tumour activity in melanoma brain metastases with encorafenib plus binimetinib: A multicenter, retrospective analysis
Lutzky, J, Holbrook, K, Amin, A, Davis, J M, Davies, M A, Diab, A, Glitza, I C, Amaria, R N, Patel, S, Tawbi, H A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1302TiPCA224-047: A randomized, double-blind, phase II/III study of relatlimab (anti-LAG-3) in combination with nivolumab (anti-PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
Lipson, E J, Long, G V, Tawbi, H, Schadendorf, D, Atkinson, V G, Maurer, M, Simonsen, K L, Harbison, C, Hodi, F S
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1379TiPA phase II, open-label, randomized, multicenter trial of encorafenib + binimetinib evaluating a standard-dose and a high-dose regimen in patients with BRAFV600-mutant melanoma brain metastasis (MBM) (POLARIS)
Davies, M A, Weber, J S, Flaherty, K T, McArthur, G A, Reddy, M B, Golden, A, Culbertson, J L, Thomas, C T, Tawbi, H A, Long, G V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1361POutcomes of patients with melanoma brain metastases (MBM) treated with standard of care therapy after being excluded from MBM-specific clinical trials
Holbrook, K, Shephard, M P, Haydu, L, Oliva, I Glitza, Amaria, R N, Patel, S, Diab, A, Hwu, P, Brown, C, Arnold, I Boesch, Burton, E, Davies, M A, Tawbi, H A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article